Genomic Vision Surge Of 3% In Five Days: What Drives It?
(VIANEWS) – Investors are enthusiastically applauding Genomic Vision (GV.PA), a French CAC 40 index company. Genomic Vision’s share price rose an impressive 3.46% over five trading sessions to EUR0.01 as of 16:21 EST Monday; this impressive performance follows two consecutive losses by this stock. Positive momentum was not restricted to GV.PA alone as the CAC…